![Aaron Goodman: For my fellow histiocytic malignancy enthusiasts!](https://oncodaily.com/pub/uploads/2023/07/Aaron-Goodman-1280x1280.jpeg)
Photo from Aaron Goodman/X
Aug 22, 2023, 09:29
Aaron Goodman: For my fellow histiocytic malignancy enthusiasts!
Quoting Aaron Goodman on Twitter/X:
“For my fellow histiocytic malignancy enthusiasts!
Discontinuation of BRAF/MEK inhibitors in histiocytic malignancies.
Paper has limitations – majority will relapse off continuous therapy. That being said, many patients can be safely observed.”
For the article click here.
Source: Aaron Goodman/Twitter
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.